(2S)-2-Methyloxolan-3-one
Common Name: |
(2S)-2-Methyloxolan-3-one |
IUPAC Name: |
(2S)-2-methyloxolan-3-one |
Molecular Formula: |
C10H18O |
SMILES: |
CC1C(=O)CCO1 |
Inchi: |
1S/C5H8O2/c1-4-5(6)2-3-7-4/h4H,2-3H2,1H3/t4-/m0/s1 |
Inchi Key: |
FCWYQRVIQDNGBI-BYPYZUCNSA-N |
Cas No: |
3188-00-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
154.25 |
Mass (g/mol) |
100.052 |
Molar Refractivity |
48.68 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
9.23 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
138.00 to 139.00 |
Vapor Pressure (mmHg@25.00 °C) |
6.556 |
Vapor Density (Air =1) |
3.4 |
Fraction Csp3 |
0.80 |
LogP |
0.364 |
iLOGP |
2.79 |
XLOGP3 |
2.89 |
WLOGP |
2.77 |
MLOGP |
2.30 |
ESOL Log S |
-2.55 |
ESOL Solubility (mg/ml) |
0.434 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.74 |
Ali Solubility (mg/ml) |
0.28 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.78 |
Silicos-IT Solubility (mg/ml) |
2.54 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.19 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.546 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
1.308 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |